CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at an average $14.24 ($85,416)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 6,000 shares at $14.27 ($85,620)
- 4 Open-market sale Chief Executive Officer sold 8,400 shares at an average $16.89 ($141,864)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 4,800 shares at an average $15.22 ($73,073)
- 4 Open-market sale Chief Medical Officer sold 6,000 shares at $15.40 ($92,400)
- 4 Open-market sale Chief Executive Officer sold 7,200 shares at an average $17.93 ($129,060)
- 4 Open-market sale Chief Executive Officer sold 12,000 shares at an average $18.34 ($220,106)
- 4 Open-market sale Chief Medical Officer sold 7,068 shares at $17.85 ($126,164)
- 4 Open-market sale Chief Operating Officer sold 1,480 shares at $18.41 ($27,247)
- 4 Exercise or conversion Chief Executive Officer acquired 5,908 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 10,503 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 1,604 shares at $19.95 ($32,000)
- 4 Open-market sale Director sold 1,184 shares at $19.35 ($22,910)
- 4 Exercise or conversion Director acquired 1,602 shares (option exercise)
Page 24 of 33 · 645 filings